Cases & Deals

Athersys completes registered direct offering of Common Stock

Clients Athersys, Inc.

Jones Day advised Athersys, Inc., a clinical stage biopharmaceutical company, in connection with its sale of 4,366,667 shares of Common Stock and Warrants to purchase an additional 1,310,000 shares of Common Stock in a registered direct offering.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.